Alloimmune thrombocytopenia.
For the fetuses who are at risk for antenatal or postnatal sequelae from AIT, prevention and treatment are now possible. This requires the attention of the obstetrician to factors in the patient's history and early referral to a center experienced in the diagnosis and management of fetal AIT.
Skupski
D W
DW
Joan and Sanford I. Weill Medical College of Cornell University, New York, New York, USA. dwskupsk@mail.med.cornell.edu
Bussel
J B
JB
D000906:Antibodies / Q000032:analysis; D016824:Antigens, Human Platelet / Q000032:analysis; D001792:Blood Platelets / Q000276:immunology; D017218:Cordocentesis; D005315:Fetal Diseases / Q000175:diagnosis* / Q000276:immunology / Q000628:therapy*; D006801:Humans; D016756:Immunoglobulins, Intravenous / Q000627:therapeutic use; D007231:Infant, Newborn; D013921:Thrombocytopenia / Q000175:diagnosis* / Q000276:immunology / Q000628:therapy*
D000906:Antibodies; D016824:Antigens, Human Platelet; D016756:Immunoglobulins, Intravenous